rxstat › Drug prices › Sarilumab

Sarilumab (Kevzara) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Sarilumab 200 mg/1.14ml solution costs about $745.69 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Sarilumab has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABSKNBNS
200 mg/1.14ml Solution$745.69/unit$745.69/unit$745.69/syringe$745.69/unit
150 mg/1.14ml Solution$745.69/unit$745.69/unit$745.69/autoinjector$745.69/unit
Plan coverageCoveredSpecial approvalSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 3 products
  • Kevzara 150 mg/1.14ml Solution · SAV
    DIN 02472961 · $745.69/unit · Covered
  • Kevzara 200 mg/1.14ml Solution · SAV
    DIN 02472988 · $745.69/unit · Covered
  • Kevzara 200 mg/1.14ml Solution · SAV
    DIN 02460548 · $745.69/unit · Covered
Saskatchewan: 3 products
  • Kevzara 150 mg/1.14ml Solution · AVT
    DIN 02472961 · $745.69/unit · Special approval
  • Kevzara 200 mg/1.14ml Solution · AVT
    DIN 02460548 · $745.69/unit · Special approval
  • Kevzara 200 mg/1.14ml Solution · AVT
    DIN 02472988 · $745.69/unit · Special approval
New Brunswick: 3 products
  • Kevzara 200 mg/1.14ml Solution · SAV
    DIN 02460548 · $745.69/syringe · Special approval
  • Kevzara 150 mg/1.14ml Solution · SAV
    DIN 02472961 · $745.69/autoinjector · Special approval
  • Kevzara 200 mg/1.14ml Solution · SAV
    DIN 02472988 · $745.69/autoinjector · Special approval
Nova Scotia: 3 products
  • Kevzara 200 mg/1.14ml Solution · SAV
    DIN 02460548 · $745.69/unit · Special approval
  • Kevzara 150 mg/1.14ml Solution · SAV
    DIN 02472961 · $745.69/unit · Special approval
  • Kevzara 200 mg/1.14ml Solution · SAV
    DIN 02472988 · $745.69/unit · Special approval

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 4
Reports on file
9

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
KEVZARA
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02472961 · ended Aug 15, 2023 · Demand increase for the drug.
Resolved
KEVZARA
200MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02460548 · ended Apr 4, 2023 · Demand increase for the drug.
Resolved
KEVZARA
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02472961 · ended Mar 14, 2023
Resolved
KEVZARA
200MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02472988 · ended Feb 10, 2023
Resolved
KEVZARA
200MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02460548 · ended Nov 30, 2022 · Demand increase for the drug.
Resolved
KEVZARA
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02472961 · ended Aug 25, 2022
Discontinued
KEVZARA
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02460521
Resolved
KEVZARA
200MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02472988 · ended Mar 5, 2020
Resolved
KEVZARA
200MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02472988 · ended May 30, 2022

What's happening

There are no active shortage reports for Sarilumab. Health Canada has 9 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Sarilumab is classified under “IMMUNOSUPPRESSANTS” (ATC L04AC).

Recent changes

Common questions

How much does Sarilumab cost in Canada?

Sarilumab 200 mg/1.14ml solution costs about $745.69 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Is Sarilumab covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Sarilumab be back in stock in Canada?

Sarilumab has no active shortage; supply is normal per Health Canada reports.

Why is Sarilumab in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (immunosuppressants)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.